Literature DB >> 10082971

Evidence for and consequences of chronic heme deficiency in Belgrade rat reticulocytes.

M D Garrick1, D Scott, D Kulju, M A Romano, K G Dolan, L M Garrick.   

Abstract

The Belgrade rat has a microcytic, hypochromic anemia inherited as an autosomal recessive trait (gene symbol b). Transferrin-dependent iron uptake is defective because of a mutation in Nramp2 (now DMT1, also called DCT1), the protein responsible for endosomal iron efflux. Hence, Belgrade reticulocytes are iron deficient. We show that a chromatographic method is able to measure the amount of 'free' heme in reticulocytes. Most of the 'free' heme is the result of biosynthesis. Succinylacetone, an inhibitor of heme synthesis, decreases the level of 'free' heme and cycloheximide, an inhibitor of globin synthesis, increases the 'free' heme level. In a pulse-chase experiment with 59Fe-transferrin, the 'free' heme pool behaves as an intermediate, with a half-life of just over 2 h. Belgrade reticulocytes contain about 40% as much 'free' heme as do heterozygous or homozygous reticulocytes. This deficiency of 'free' heme slows initiation of translation in Belgrade reticulocytes by increasing the level of an inhibitor of initiation. Thus the Belgrade rat makes a whole animal model available with chronic heme deficiency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082971     DOI: 10.1016/s0167-4889(99)00006-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.

Authors:  Daniel Garcia-Santos; Amel Hamdi; Zuzana Saxova; Carine Fillebeen; Kostas Pantopoulos; Monika Horvathova; Prem Ponka
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

Review 2.  Pharmacology of iron transport.

Authors:  Shaina L Byrne; Divya Krishnamurthy; Marianne Wessling-Resnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

3.  Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor rev-erb{beta}.

Authors:  Nirupama Gupta; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

4.  Redox status affects the catalytic activity of glutamyl-tRNA synthetase.

Authors:  Assaf Katz; Rajat Banerjee; Merly de Armas; Michael Ibba; Omar Orellana
Journal:  Biochem Biophys Res Commun       Date:  2010-06-10       Impact factor: 3.575

5.  Identification of a thiol/disulfide redox switch in the human BK channel that controls its affinity for heme and CO.

Authors:  Li Yi; Jeffrey T Morgan; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

6.  Mammal cells double their total RNAs against diabetes, ischemia reperfusion and malaria-induced oxidative stress.

Authors:  Zhong-Wei Zhang; Jian Cheng; Fei Xu; Ming Yuan; Jun-Bo Du; Jing Shang; Yong Wang; Lei Du; Zi-Lin Li; Shu Yuan
Journal:  Mol Med       Date:  2010-12-08       Impact factor: 6.354

7.  High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor.

Authors:  Eric L Carter; Nirupama Gupta; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

8.  Evidence that the heme regulatory motifs in heme oxygenase-2 serve as a thiol/disulfide redox switch regulating heme binding.

Authors:  Li Yi; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

9.  Heme regulates allosteric activation of the Slo1 BK channel.

Authors:  Frank T Horrigan; Stefan H Heinemann; Toshinori Hoshi
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

Review 10.  Pathophysiology of the Belgrade rat.

Authors:  Tania Veuthey; Marianne Wessling-Resnick
Journal:  Front Pharmacol       Date:  2014-04-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.